The UK medical research sector is uniting to support the introduction of dedicated sex and gender policies in biomedical research. This movement is evidenced by a collective endorsement from 29 organizations, including key research funders and academic publishers, in alignment with The George Institute for Global Health’s Medical Science Sex and Gender Equity (MESSAGE) project. These organizations contribute an estimated £4.1 billion…
Maven Clinic recently published peer-reviewed research in “Obstetrics and Gynecology,” presenting a comprehensive analysis of the effects of virtual doula care on maternal health outcomes. This first-of-its-kind study, which draws from data involving nearly 9,000 Maven members, examines the comparative efficacy of virtual doula care to traditional in-person support. The research underscores that virtual doula care can improve birth experiences and reduce…
TMRW Life Sciences, known for its automation technology in IVF labs, has announced its expansion into the United Kingdom. This strategic move introduces the company’s advanced CryoRobot Select (CRS) system to the UK market, starting with The Hewitt Fertility Centre in Liverpool. The CRS system automates the storage and management of frozen eggs and embryos, aiming to enhance safety and efficiency in…
2023? It’s a wrap! And as every year we want to take a look back today at the year that was in the world of women’s health innovation. Our Weekly Femtech Insider Brief has been at the center of our work since our launch in 2019. So what better way to reflect than to take a look at the headlines, that got thousands in…
Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights Sustainable femcare brand Yoni raises €2.3M for European expansion. Biorithm secures $3.5M in Series A funding for its obstetric remote monitoring solution. Lunit targets US market with $193M acquisition of AI-enabled breast…
As we navigate towards the end of the transformative year 2023 was in so many ways, it’s clear that AI is not just a buzzword but a game-changer across many industries including media. At Femtech Insider, we’re ever so curious when it comes to innovation and of course we do the best to keep up and evolve our platform to best serve…
Organon and Eli Lilly and Company (Lilly) have announced a commercialization agreement that positions Organon as the exclusive distributor and promoter of two migraine medicines, Emgality (galcanezumab) and RAYVOW (lasmiditan), in Europe. Organon, a global healthcare company with a focus on women’s health, will leverage its experience in central nervous system disorders to promote and distribute these medications. Emgality is a humanized…
Singapore-based MedTech firm Biorithm has successfully closed a $3.5M Series A funding round, co-led by Adaptive Capital Partners and SEEDS Capital, the investment arm of government agency Enterprise Singapore. This funding will support the expansion of Biorithm’s connected pregnancy management solutions in Southeast Asia and the United States. It also will assist the company in advancing Femom, a comprehensive obstetric remote monitoring…